Skip to content

Twist Bioscience Corporation TWST Reportable Segment — Impairment of long-lived assets

Similar metrics at other companies

WillScot Holdings Corporation logo
WSCReportable Segment — Impairment loss on long-lived asset
$0-100%
Baxter International logo
BAXReportable Segment — Indefinite-lived asset impairments
-$72.5M-480%
Incyte logo
INCYReportable Segment — Asset impairment
$19.07M
Synaptics logo
SYNAReportable Segment — Intangible asset impairment charge
$3.45M-13.8%
New York Times logo
NYTReportable Segment — Impairment Charges
$714.5K
Primo Brands logo
PRMBReportable Segment — Intangible asset impairment
$8.9M

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.

The official record: Twist Bioscience Corporation’s 10-K, filed November 17, 2025, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's reportable segment — impairment of long-lived assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's reportable segment — impairment of long-lived assets?
Twist Bioscience Corporation (TWST) reported reportable segment — impairment of long-lived assets of $0 in Q3 2025.
How has Twist Bioscience Corporation's reportable segment — impairment of long-lived assets changed year-over-year?
Twist Bioscience Corporation's reportable segment — impairment of long-lived assets decreased by 100.0% year-over-year, from $11.23M to $0.
What is the long-term trend for Twist Bioscience Corporation's reportable segment — impairment of long-lived assets?
Over 2 years (2023 to 2025), Twist Bioscience Corporation's reportable segment — impairment of long-lived assets has grown at a -100.0% compound annual growth rate (CAGR), from $6.79M to $0.
What does reportable segment — impairment of long-lived assets mean?
This represents a non-cash charge recognized when the carrying value of the reportable segment's long-term assets, such as property, plant, or equipment, exceeds their recoverable amount. It serves as an indicator that the expected future economic benefits from these assets have declined. Significant impairments often signal a strategic reassessment of the segment's asset base or market conditions.